Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial.
Saved in:
| Title: | Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial. |
|---|---|
| Authors: | Laval J; Givaudan France Naturals, 250 rue Pierre Bayle, Avignon 84911, France., Phipps KR; Intertek Health Sciences Inc., Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire GU14 0LX, United Kingdom., Brinet S; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France., Fournier MC; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France., Douillard B; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France., Pham S; Intertek Health Sciences Inc., 2233 Argentia Road, Suite 201, Mississauga, Ontario L5N 2×7, Canada., Lobach A; Givaudan Canada Co., 2855 Argentia Road, Unit 1, Mississauga, Ontario L5N 8G6, Canada., Mueller S; Givaudan International SA, Kemptpark 50, Kemptthal 8310, Switzerland., Fança-Berthon P; Givaudan France Naturals, 250 rue Pierre Bayle, Avignon 84911, France. |
| Source: | Toxicology reports [Toxicol Rep] 2025 Nov 29; Vol. 16, pp. 102176. Date of Electronic Publication: 2025 Nov 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Ireland Ltd Country of Publication: Ireland NLM ID: 101630272 Publication Model: eCollection Cited Medium: Internet ISSN: 2214-7500 (Electronic) Linking ISSN: 22147500 NLM ISO Abbreviation: Toxicol Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41459382 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Laval+J%22">Laval J</searchLink>; Givaudan France Naturals, 250 rue Pierre Bayle, Avignon 84911, France.<br /><searchLink fieldCode="AU" term="%22Phipps+KR%22">Phipps KR</searchLink>; Intertek Health Sciences Inc., Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire GU14 0LX, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brinet+S%22">Brinet S</searchLink>; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France.<br /><searchLink fieldCode="AU" term="%22Fournier+MC%22">Fournier MC</searchLink>; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France.<br /><searchLink fieldCode="AU" term="%22Douillard+B%22">Douillard B</searchLink>; Biofortis, 3 route de la Chatterie, Saint Herblain 44800, France.<br /><searchLink fieldCode="AU" term="%22Pham+S%22">Pham S</searchLink>; Intertek Health Sciences Inc., 2233 Argentia Road, Suite 201, Mississauga, Ontario L5N 2×7, Canada.<br /><searchLink fieldCode="AU" term="%22Lobach+A%22">Lobach A</searchLink>; Givaudan Canada Co., 2855 Argentia Road, Unit 1, Mississauga, Ontario L5N 8G6, Canada.<br /><searchLink fieldCode="AU" term="%22Mueller+S%22">Mueller S</searchLink>; Givaudan International SA, Kemptpark 50, Kemptthal 8310, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fança-Berthon+P%22">Fança-Berthon P</searchLink>; Givaudan France Naturals, 250 rue Pierre Bayle, Avignon 84911, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101630272%22">Toxicology reports</searchLink> [Toxicol Rep] 2025 Nov 29; Vol. 16, pp. 102176. <i>Date of Electronic Publication: </i>2025 Nov 29 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ireland+Ltd%22">Elsevier Ireland Ltd </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>101630272 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2214-7500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222147500%22">22147500 </searchLink><i>NLM ISO Abbreviation: </i>Toxicol Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41459382 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.toxrep.2025.102176 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102176 Titles: – TitleFull: Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laval J – PersonEntity: Name: NameFull: Phipps KR – PersonEntity: Name: NameFull: Brinet S – PersonEntity: Name: NameFull: Fournier MC – PersonEntity: Name: NameFull: Douillard B – PersonEntity: Name: NameFull: Pham S – PersonEntity: Name: NameFull: Lobach A – PersonEntity: Name: NameFull: Mueller S – PersonEntity: Name: NameFull: Fança-Berthon P IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 11 Text: 2025 Nov 29 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2214-7500 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Toxicology reports Type: main |
| ResultId | 1 |
